Private equity firm Warburg Pincus is looking to sell the company for at least $10 billion.
The companies reported to have shown interest are Abbott Laboratories, Johnson & Johnson and Sanofi.
Related Articles on Ophthalmology:
Study: Changes in Retinal Blood Vessels May Indicate Increased Glaucoma Risk
Ophthalmologist Dr. Jonathan Dutton Appointed Visiting Professor at University of Amsterdam
Ophthalmologist on the Move: Dr. Wendewessen Amde Joins IL’s Silver Cross Hospital
